Defunct Company
Total Trials
12
As Lead Sponsor
0
As Collaborator
Total Enrollment
425
NCT00652704
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions
Phase: Phase 1
Role: Collaborator
Start: Jul 31, 1999
Completion: Sep 30, 1999
NCT00653380
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions
Start: Sep 30, 1999
Completion: Oct 31, 1999
NCT01380496
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions
Start: Nov 30, 1999
Completion: Nov 30, 1999
NCT01380483
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions
Start: Jan 31, 2000
Completion: Apr 30, 2000
NCT00653549
Bioavailability Study of Torsemide Tablets Under Fasting Conditions
Start: Apr 30, 2001
Completion: May 31, 2001
NCT00654043
Bioavailability Study of Torsemide Tablets Under Fed Conditions
NCT00652873
Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions
Start: Jul 31, 2001
Completion: Dec 31, 2001
NCT00653055
Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
Start: Aug 31, 2001
NCT00652795
Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions
Start: Jul 31, 2004
Completion: Sep 30, 2004
NCT00734240
Safety and Tolerability of Single and Multiple Doses of ISIS 353512 in Healthy Volunteers
Start: Jul 31, 2008
Completion: Mar 31, 2010
NCT05014490
Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers
Start: Feb 24, 2021
Completion: Mar 24, 2021
NCT06133478
Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants
Start: Nov 9, 2023
Completion: Apr 5, 2024